Technology areas: Biotechnology & Pharmaceuticals • Chemistry & Materials
4 pending office actions • 4 art units • 4 examiners • 0 of 4 (0%) have an AI response strategy ready • 3 patents granted in the last 365 days
Paul Hartmann AG is currently overseeing 4 pending office actions in the Biotechnology & Pharmaceuticals technology area. These actions are distributed among 4 distinct examiners and 4 distinct art units. This one-to-one ratio between the 4 pending office actions and the 4 distinct examiners indicates that every active matter is being reviewed by a different individual, ensuring a variety of perspectives across the portfolio.
The busiest examiner, YOO, REGINA M, is responsible for 1 pending office action. This matches the workload of every other examiner involved, as the 4 pending office actions are spread perfectly across 4 distinct examiners. Navigating 4 distinct art units requires the company to address a variety of technical requirements and examination styles within the pharmaceutical field.
With 4 pending office actions currently in progress, the company maintains a broad front of intellectual property development. The involvement of 4 distinct art units suggests that the underlying technologies are diverse enough to fall under multiple specialized classifications. Practitioners must account for the perspectives of 4 different examiners to successfully advance these 4 pending actions.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 1 (25%) |
| §103 only | 1 (25%) |
| §112 only | 2 (50%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| YOO, REGINA M | 1 | 63.8% | +5.8% |
| WITHERSPOON, SIKARL A | 1 | 86.3% | -20.1% |
| FUBARA, BLESSING M | 1 | 62.2% | +34.1% |
| CLARKE, TRENT R | 1 | 42.2% | +24.7% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18580551 | IRRADIATION CROSSLINKING AND STERILIZATION OF SILICONE | WITHERSPOON, SIKARL A | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17920142 | METHOD AND DEVICE FOR ASSESSING A STATUS OF A WOUND OF A PATIENT | CLARKE, TRENT R | 42d overdue |
| 18269233 | HYDROGEL FOR TREATING PRESSURE ULCERS | FUBARA, BLESSING M | — |
| Art Unit | Apps |
|---|---|
| 1758 | 1 |
| 1692 | 1 |
| 1613 | 1 |
| 1657 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18722249 | IN-LINE RADIATION STERILIZATION FOR WOUND DRESSINGS | YOO, REGINA M | 1758 | §112 | Non-Final OA | — | Pending | Jun 20, 2024 |
| 18580551 | IRRADIATION CROSSLINKING AND STERILIZATION OF SILICONE | WITHERSPOON, SIKARL A | 1692 | §101§103§112 | Non-Final OA | — | Pending | Jan 18, 2024 |
| 18269233 | HYDROGEL FOR TREATING PRESSURE ULCERS | FUBARA, BLESSING M | 1613 | §112 | Final Rejection | — | Pending | Jun 22, 2023 |
| 17920142 | METHOD AND DEVICE FOR ASSESSING A STATUS OF A WOUND OF A PATIENT | CLARKE, TRENT R | 1657 | §103Other | Final Rejection | 42d overdue | Pending | Oct 20, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialPaul Hartmann AG has 4 pending office actions as of October 2026, spread across 4 art units and 4 examiners.
Regina M Yoo has the most, with 1 of Paul Hartmann AG's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
